Scherago International has announced "Biosimilars 2007," a two day conference to "air the issues" and "raise the questions" associated with biosimilars (also called follow-on biologics or biogenerics). The conference will be held September 24-25 in the Jack Morton Auditorium on the campus of George Washington University, in Washington D.C.
Speakers include leaders in Congress working on biosimilars legislation--including Congressman Henry Waxman--as well as leaders and experts from the FDA, industry, public organizations and consumer groups. Panel discussions will add to the presentation of the many issues and allow the audience to ask questions of the speakers.
The conference will include five main sessions:
- Legislation in the US, EU, and Japan
- Policy
- Legal/Patent
- Economic and Financial
- Regulatory/Scientific & Technical
According to the conference organizers, those who should attend include:
- Legal Affairs / Corporate Strategy / Regulatory Affairs
- Intellectual Property / Patent Attorneys / Regulatory Compliance
- New Product Development / Business Development / Business Operations
- Project Management / Laboratory Heads/Chiefs / Scientific Affairs
- Principal Scientists / Chief Scientific Officer
For additional information or to register, please visit the conference website.
Orange Book Blog is a media partner of this conference.
Comments